Abstract
Multisystem inflammatory syndrome in children is a rare, potentially life-threatening postinfectious complication in children after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. It is currently unknown if multisystem inflammatory syndrome in children (MIS-C) can recur upon reinfection with SARS-CoV-2. Here, we report on a former MIS-C patient who was reinfected with SARS-CoV-2 without recurrence of MIS-C.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Biomarkers
-
COVID-19 / complications*
-
Female
-
Humans
-
Immunoglobulins, Intravenous / therapeutic use
-
Inflammation / blood
-
Inflammation / metabolism
-
Methylprednisolone / therapeutic use
-
Prednisone / therapeutic use
-
Recurrence
-
Reinfection
-
SARS-CoV-2*
-
Systemic Inflammatory Response Syndrome / complications*
Substances
-
Biomarkers
-
Immunoglobulins, Intravenous
-
Prednisone
-
Methylprednisolone
Supplementary concepts
-
pediatric multisystem inflammatory disease, COVID-19 related